Nanopore Sequencing Market PowerPoint PPT Presentations

The global metagenomic sequencing market size was worth USD 1,355 million in 2021 and is expected to reach USD 5,785 million by 2030, growing at a CAGR of 17.5% during the forecast period (2022–2030).

Global Market Insights Inc. Add New Report Global Next Generation Sequencing Market to its database which covers the market landscape and its growth prospects over the coming years.

Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through tiny protein channel called as nanopore.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understanding its evolution or function. DNA sequencing helps in the understanding of genetic biology and the technique is now widely being used in the field of medical research. Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used globally.

According to #TechSci Research report, Global Nanopore Sequencing Market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% during the forecast period. Gain more Insight: https://bit.ly/2TWAQZ4 Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

Global Next Generation Sequencing Market by The Business Research Company is segmented as NextSeq Systems, MiniSeq Systems, NovaSeq Systems, iSeq 100 Systems, Ion PGM Systems, Ion Proton Systems, Ion GeneStudio S5 Systems https://bit.ly/3xBiA6f

DNA sequencing is a technology in which several DNA strands can be sequenced through massive parallelization. This sequencing includes both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Read More@ https://www.alliedmarketresearch.com/dna-sequencing-market

Bioinformatics Market - Nanopore Sequencing Technology and Cloud Technology, Increasing Adoption of Bioinformatics Tools leading to growth opportunity

Global sequencing reagents market is expected to rise to an estimated value of USD 12.45 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the various innovations and advancement of techniques of sequencing.

The global next generation sequencing market was valued at $13 billion in 2023, and is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035.

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Next Generation Sequencing (NGS) Market Statistics, Emerging Demands and Forecast to 2030

NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027

The global long read sequencing market was valued at USD 825.80million in 2019 and is expected to grow at 24.29% CAGR during the forecast period.

. As a result, it has found applications in diverse fields, ranging from medical diagnostics and pharmaceutical research to agriculture and environmental studies

Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the technology for diverse pharmaceutical & biopharmaceutical applications.

The global long read sequencing market was valued at USD 825.80million in 2019 and is expected to grow at 24.29% CAGR during the forecast period.

The global metagenomics sequencing market size was valued at USD 974.3 million in 2020 and is expected to reach USD 2,564.01 million by 2027, with a CAGR of 17.5% during the forecast period.

Global DNA Sequencing Market size is projected to be valued $26 Billion by 2025; with a CAGR of 18.7% from 2017 to 2025. DNA sequencing is the blueprint which contains genetic information, used in understan

According to the latest research report by IMARC Group, The global nanopore technologies market size reached US$ 276.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 753.6 Million by 2032, exhibiting a growth rate (CAGR) of 11.4% during 2024-2032. More Info:- https://www.imarcgroup.com/nanopore-technologies-market

Read here the latest updates on the Immune Repertoire Sequencing Market Analysis published by CMI team

Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025. Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform & Consumable" provides Next Generation Sequencing Market. Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php

Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

According to the latest research report by IMARC Group, The United States next generation sequencing market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-next-generation-sequencing-market

Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

According to our new research study on “miRNA Sequencing and Assay Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Technology, and End User,” the market is expected to reach US$ 468.99 million by 2027 from US$ 192.31 million in 2019; it is estimated to grow at a CAGR of 11.9% from 2020 to 2027. The report highlights trends prevailing in the miRNA sequencing and assay market along with the factors governing its growth.

According to the latest research report by IMARC Group, The global nanopore technologies market size reached US$ 244.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 511.5 Million by 2028, exhibiting a growth rate (CAGR) of 12.4% during 2023-2028. More Info:- https://www.imarcgroup.com/nanopore-technologies-market

marketreportslibrary.com has published new market report on “Next generation Sequencing Market” in the Healthcare Industry

According to the latest research report by IMARC Group, The global microbiome sequencing services market size reached US$ 1,846.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 5,568.4 Million by 2028, exhibiting a growth rate (CAGR) of 20% during 2023-2028. More Info:- https://www.imarcgroup.com/microbiome-sequencing-services-market

The DNA next generation sequencing market size is estimated to reach US$ 22,716.9 million by 2025 from US$ 4,898.5 million in 2017; it is expected to grow at a CAGR of 21.7% during 2018-2025.

Global Mobile Apps for DNA Sequencing Market is expected to grow at a CAGR of 53.9% from 2017 to 2025. The report highlights the key trends, market outlook

Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

Major players in the next-generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc, BGI Group, Agilent Technologies Inc..... @ @ https://bit.ly/3H8wBgc

TBRC global clinical oncology next generation sequencing market report includes ion semiconductor sequencing, pyro-sequencing, synthesis sequencing, real time sequencing.

Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

The global metagenomics sequencing market size was valued at USD 974.3 million in 2020 and is expected to reach USD 2,564.01 million by 2027, with a CAGR of 17.5% during the forecast period.

The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.

Major players in the next generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc...@ @ https://bit.ly/3H8wBgc

DNA Sequencing Market Segmented By Applications such as Forensics, Research, Diagnostics, Treatment analysis and Personalized genomics

The rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is propelling the development is propelling the development of next generation sequencing market.

The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7S

The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7SB

iGATE Research has released a research report on “Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=165 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

Sequencing reagents are defined as specific substances which are used in a variety of sequencing-related research projects. These reagents operate on the same concept as traditional reagents which are required for initiating a chemical reaction. These compounds are made up of a variety of components that work together to produce the desired reaction in a research study.

Major players in the next generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc., Qiagen N.V., Hoffmann-La Roche AG, Eurofins Scientific Read More @ https://bit.ly/3tceS00

This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.

Global Clinical Oncology Next Generation Sequencing Market by The Business Research Company is segmented as Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing https://bit.ly/3yNlUvg

MiRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Library Preparation and Consumables), Technology (Sequencing By Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO) By Geography

The major player covered in the clinical oncology next generation sequencing global market report are Thermo Fisher Scientific(Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics,

The global nanopore technologies market reached a value of US$ 213.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 476.6 Million by 2027, exhibiting at a CAGR of 13.7% during 2022-2027. More info:- https://www.imarcgroup.com/nanopore-technologies-market

Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Companies in the clinical oncology next generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample to sample variability.

TechNavios analysts forecast the Global DNA Sequencing Equipment and Services market to grow at a CAGR of 20.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements witnessed in R&D divisions.

However, accuracy & standardization concerns in diagnostic testing, lack of skilled professionals, and ethical & legal issues related to NGS are some of the key factors restraining the growth of this market. In addition to this, challenges associated with interpretation of complex data from NGS platforms and storage of sequencing data also limits the growth of the NGS market.